Brief: PolyPeptide Group H1 Revenue EUR 236.628 Million
13/08/2026 06:01
BRIEF-PolyPeptide Group H1 Revenue EUR 236.628 Million Aug 13 (Reuters) - PolyPeptide Group H1 capex EUR 41.318 million.
- H1 cash flow from operating activities EUR 25.219 million
- H1 net income EUR 9.081 million
- H1 EBITDA EUR 49.091 million
- H1 EBIT EUR 21.979 million
Recent news on PolyPeptide AG
See all newsBrief: Polypeptide Group Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics
Brief: Polypeptide Group Provisional Interim Result Of The Public Tender Offer Of Samsung Biologics Co
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Samsung Biologics to launch takeover bid for PolyPeptide in September (updated)